A Phase 1/2 Study Evaluating ABT-751 in Combination With Alimta in Advanced Non-Small Cell Lung Cancer

Mise à jour : Il y a 4 ans
Référence : NCT00297089

Femme et Homme

Extrait

To determine the efficacy of ABT-751 when administered in combination with standard pemetrexed in subjects with advanced or metastatic NSCLC. The Phase 1 portion of the study is complete and the study is currently enrolling subjects in Phase 2.


Critère d'inclusion

  • Lung cancer ,NSCLC ,non-small cell lung cancer


Liens